nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—Dronabinol—CYP1A1—chronic obstructive pulmonary disease	0.0228	1	CrCbGaD
Nabilone—CNR1—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	0.00289	0.0639	CbGpPWpGaD
Nabilone—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00203	0.00218	CcSEcCtD
Nabilone—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00202	0.00216	CcSEcCtD
Nabilone—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00202	0.00216	CcSEcCtD
Nabilone—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00201	0.00216	CcSEcCtD
Nabilone—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00199	0.00214	CcSEcCtD
Nabilone—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.00198	0.00212	CcSEcCtD
Nabilone—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00198	0.00212	CcSEcCtD
Nabilone—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00198	0.00212	CcSEcCtD
Nabilone—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00198	0.00212	CcSEcCtD
Nabilone—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00196	0.0021	CcSEcCtD
Nabilone—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00196	0.0021	CcSEcCtD
Nabilone—Cough—Formoterol—chronic obstructive pulmonary disease	0.00195	0.00209	CcSEcCtD
Nabilone—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00195	0.00209	CcSEcCtD
Nabilone—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00194	0.00208	CcSEcCtD
Nabilone—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00193	0.00208	CcSEcCtD
Nabilone—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00193	0.00207	CcSEcCtD
Nabilone—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00193	0.00207	CcSEcCtD
Nabilone—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00193	0.00207	CcSEcCtD
Nabilone—Cough—Montelukast—chronic obstructive pulmonary disease	0.00191	0.00205	CcSEcCtD
Nabilone—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.0019	0.00204	CcSEcCtD
Nabilone—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.0019	0.00204	CcSEcCtD
Nabilone—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.0019	0.00204	CcSEcCtD
Nabilone—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.0019	0.00204	CcSEcCtD
Nabilone—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.0019	0.00204	CcSEcCtD
Nabilone—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.0019	0.00204	CcSEcCtD
Nabilone—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.0019	0.00204	CcSEcCtD
Nabilone—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.0019	0.00204	CcSEcCtD
Nabilone—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.0019	0.00204	CcSEcCtD
Nabilone—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.0019	0.00203	CcSEcCtD
Nabilone—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.0019	0.00203	CcSEcCtD
Nabilone—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.0019	0.00203	CcSEcCtD
Nabilone—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00189	0.00203	CcSEcCtD
Nabilone—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00189	0.00203	CcSEcCtD
Nabilone—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00189	0.00203	CcSEcCtD
Nabilone—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00188	0.00202	CcSEcCtD
Nabilone—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00188	0.00202	CcSEcCtD
Nabilone—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00187	0.002	CcSEcCtD
Nabilone—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00186	0.002	CcSEcCtD
Nabilone—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00186	0.002	CcSEcCtD
Nabilone—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00186	0.002	CcSEcCtD
Nabilone—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00186	0.002	CcSEcCtD
Nabilone—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00186	0.00199	CcSEcCtD
Nabilone—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00186	0.00199	CcSEcCtD
Nabilone—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00185	0.00198	CcSEcCtD
Nabilone—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00184	0.00198	CcSEcCtD
Nabilone—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00182	0.00196	CcSEcCtD
Nabilone—Infection—Formoterol—chronic obstructive pulmonary disease	0.00181	0.00194	CcSEcCtD
Nabilone—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00181	0.00194	CcSEcCtD
Nabilone—CNR1—GPCRs, Other—ADRB2—chronic obstructive pulmonary disease	0.00181	0.0401	CbGpPWpGaD
Nabilone—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.0018	0.00193	CcSEcCtD
Nabilone—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.0018	0.00193	CcSEcCtD
Nabilone—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.0018	0.00193	CcSEcCtD
Nabilone—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00179	0.00192	CcSEcCtD
Nabilone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00179	0.00192	CcSEcCtD
Nabilone—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00178	0.00191	CcSEcCtD
Nabilone—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00178	0.00191	CcSEcCtD
Nabilone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00178	0.0019	CcSEcCtD
Nabilone—Infection—Montelukast—chronic obstructive pulmonary disease	0.00178	0.0019	CcSEcCtD
Nabilone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00177	0.00189	CcSEcCtD
Nabilone—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00176	0.00189	CcSEcCtD
Nabilone—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.00176	0.00188	CcSEcCtD
Nabilone—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.00173	0.00186	CcSEcCtD
Nabilone—CNR2—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.00172	0.0381	CbGpPWpGaD
Nabilone—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00171	0.00184	CcSEcCtD
Nabilone—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.0017	0.00183	CcSEcCtD
Nabilone—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.0017	0.00183	CcSEcCtD
Nabilone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.0017	0.00182	CcSEcCtD
Nabilone—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00169	0.00182	CcSEcCtD
Nabilone—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00169	0.00182	CcSEcCtD
Nabilone—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00168	0.0018	CcSEcCtD
Nabilone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00167	0.00179	CcSEcCtD
Nabilone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00167	0.00179	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00166	0.00178	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00166	0.00178	CcSEcCtD
Nabilone—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00165	0.00177	CcSEcCtD
Nabilone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00165	0.00177	CcSEcCtD
Nabilone—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00164	0.00176	CcSEcCtD
Nabilone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00164	0.00176	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00163	0.00175	CcSEcCtD
Nabilone—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00163	0.00175	CcSEcCtD
Nabilone—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00163	0.00175	CcSEcCtD
Nabilone—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00162	0.00174	CcSEcCtD
Nabilone—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00162	0.00174	CcSEcCtD
Nabilone—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00162	0.00173	CcSEcCtD
Nabilone—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00161	0.00173	CcSEcCtD
Nabilone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00161	0.00172	CcSEcCtD
Nabilone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00161	0.00172	CcSEcCtD
Nabilone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.0016	0.00172	CcSEcCtD
Nabilone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.0016	0.00172	CcSEcCtD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.0016	0.0354	CbGpPWpGaD
Nabilone—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00159	0.0017	CcSEcCtD
Nabilone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00159	0.0017	CcSEcCtD
Nabilone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00157	0.00169	CcSEcCtD
Nabilone—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00157	0.00169	CcSEcCtD
Nabilone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00157	0.00169	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00157	0.00168	CcSEcCtD
Nabilone—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00156	0.00167	CcSEcCtD
Nabilone—Pain—Formoterol—chronic obstructive pulmonary disease	0.00156	0.00167	CcSEcCtD
Nabilone—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00156	0.00167	CcSEcCtD
Nabilone—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00156	0.00167	CcSEcCtD
Nabilone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.00167	CcSEcCtD
Nabilone—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.00155	0.00167	CcSEcCtD
Nabilone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00155	0.00166	CcSEcCtD
Nabilone—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00154	0.00165	CcSEcCtD
Nabilone—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00154	0.00165	CcSEcCtD
Nabilone—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00153	0.00164	CcSEcCtD
Nabilone—Pain—Montelukast—chronic obstructive pulmonary disease	0.00153	0.00164	CcSEcCtD
Nabilone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00152	0.00164	CcSEcCtD
Nabilone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00152	0.00163	CcSEcCtD
Nabilone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00151	0.00162	CcSEcCtD
Nabilone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00151	0.00162	CcSEcCtD
Nabilone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.0015	0.00161	CcSEcCtD
Nabilone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.0015	0.00161	CcSEcCtD
Nabilone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.0015	0.00161	CcSEcCtD
Nabilone—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.0015	0.00161	CcSEcCtD
Nabilone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00149	0.0016	CcSEcCtD
Nabilone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00149	0.0016	CcSEcCtD
Nabilone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00149	0.0016	CcSEcCtD
Nabilone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00149	0.00159	CcSEcCtD
Nabilone—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00147	0.00158	CcSEcCtD
Nabilone—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00147	0.00158	CcSEcCtD
Nabilone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00146	0.00157	CcSEcCtD
Nabilone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00144	0.00155	CcSEcCtD
Nabilone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00144	0.00155	CcSEcCtD
Nabilone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00144	0.00155	CcSEcCtD
Nabilone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00144	0.00155	CcSEcCtD
Nabilone—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.00144	0.00154	CcSEcCtD
Nabilone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00144	0.00154	CcSEcCtD
Nabilone—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.00143	0.00153	CcSEcCtD
Nabilone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00143	0.00153	CcSEcCtD
Nabilone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00142	0.00153	CcSEcCtD
Nabilone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00142	0.00153	CcSEcCtD
Nabilone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.00152	CcSEcCtD
Nabilone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00142	0.00152	CcSEcCtD
Nabilone—CNR1—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	0.00142	0.0314	CbGpPWpGaD
Nabilone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00141	0.00152	CcSEcCtD
Nabilone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00141	0.00152	CcSEcCtD
Nabilone—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.00141	0.00151	CcSEcCtD
Nabilone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00151	CcSEcCtD
Nabilone—Irritability—Prednisone—chronic obstructive pulmonary disease	0.00139	0.0015	CcSEcCtD
Nabilone—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.00138	0.00148	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00137	0.0303	CbGpPWpGaD
Nabilone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00136	0.00146	CcSEcCtD
Nabilone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00136	0.00146	CcSEcCtD
Nabilone—CNR1—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.00135	0.0299	CbGpPWpGaD
Nabilone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00134	0.00144	CcSEcCtD
Nabilone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00134	0.00144	CcSEcCtD
Nabilone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00134	0.00144	CcSEcCtD
Nabilone—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00134	0.00144	CcSEcCtD
Nabilone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00141	CcSEcCtD
Nabilone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00131	0.0014	CcSEcCtD
Nabilone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.0014	CcSEcCtD
Nabilone—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00129	0.00138	CcSEcCtD
Nabilone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00129	0.00138	CcSEcCtD
Nabilone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00128	0.00138	CcSEcCtD
Nabilone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00136	CcSEcCtD
Nabilone—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00126	0.00136	CcSEcCtD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.00125	0.0278	CbGpPWpGaD
Nabilone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00134	CcSEcCtD
Nabilone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00134	CcSEcCtD
Nabilone—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00124	0.00133	CcSEcCtD
Nabilone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00133	CcSEcCtD
Nabilone—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00123	0.00132	CcSEcCtD
Nabilone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00131	CcSEcCtD
Nabilone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.00131	CcSEcCtD
Nabilone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00121	0.00129	CcSEcCtD
Nabilone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.00129	CcSEcCtD
Nabilone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00127	CcSEcCtD
Nabilone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00126	CcSEcCtD
Nabilone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00124	CcSEcCtD
Nabilone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00124	CcSEcCtD
Nabilone—Rash—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00123	CcSEcCtD
Nabilone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00123	CcSEcCtD
Nabilone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00123	CcSEcCtD
Nabilone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00123	CcSEcCtD
Nabilone—Headache—Formoterol—chronic obstructive pulmonary disease	0.00114	0.00123	CcSEcCtD
Nabilone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00114	0.00123	CcSEcCtD
Nabilone—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00114	0.00122	CcSEcCtD
Nabilone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00122	CcSEcCtD
Nabilone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00122	CcSEcCtD
Nabilone—Rash—Montelukast—chronic obstructive pulmonary disease	0.00113	0.00121	CcSEcCtD
Nabilone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00113	0.00121	CcSEcCtD
Nabilone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00112	0.00121	CcSEcCtD
Nabilone—Depression—Prednisone—chronic obstructive pulmonary disease	0.00112	0.0012	CcSEcCtD
Nabilone—Headache—Montelukast—chronic obstructive pulmonary disease	0.00112	0.0012	CcSEcCtD
Nabilone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00118	CcSEcCtD
Nabilone—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00109	0.00117	CcSEcCtD
Nabilone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00109	0.00117	CcSEcCtD
Nabilone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00117	CcSEcCtD
Nabilone—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00109	0.00116	CcSEcCtD
Nabilone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00116	CcSEcCtD
Nabilone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00116	CcSEcCtD
Nabilone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00116	CcSEcCtD
Nabilone—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00116	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00107	0.0238	CbGpPWpGaD
Nabilone—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00106	0.00114	CcSEcCtD
Nabilone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00114	CcSEcCtD
Nabilone—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00105	0.00113	CcSEcCtD
Nabilone—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00105	0.00112	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00104	0.0231	CbGpPWpGaD
Nabilone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.0011	CcSEcCtD
Nabilone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00102	0.00109	CcSEcCtD
Nabilone—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00108	CcSEcCtD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.001	0.0222	CbGpPWpGaD
Nabilone—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000972	0.00104	CcSEcCtD
Nabilone—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000964	0.00103	CcSEcCtD
Nabilone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000955	0.00102	CcSEcCtD
Nabilone—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000944	0.00101	CcSEcCtD
Nabilone—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000938	0.00101	CcSEcCtD
Nabilone—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000903	0.000969	CcSEcCtD
Nabilone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000894	0.000959	CcSEcCtD
Nabilone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000887	0.000952	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000859	0.019	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000854	0.0189	CbGpPWpGaD
Nabilone—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000845	0.000907	CcSEcCtD
Nabilone—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000829	0.00089	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000818	0.0181	CbGpPWpGaD
Nabilone—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000816	0.000876	CcSEcCtD
Nabilone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000814	0.000874	CcSEcCtD
Nabilone—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000813	0.000872	CcSEcCtD
Nabilone—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000808	0.000867	CcSEcCtD
Nabilone—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000793	0.000851	CcSEcCtD
Nabilone—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00079	0.000848	CcSEcCtD
Nabilone—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000789	0.000846	CcSEcCtD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000787	0.0174	CbGpPWpGaD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000784	0.0174	CbGpPWpGaD
Nabilone—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000773	0.00083	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000768	0.017	CbGpPWpGaD
Nabilone—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000762	0.000818	CcSEcCtD
Nabilone—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000759	0.000815	CcSEcCtD
Nabilone—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000749	0.000804	CcSEcCtD
Nabilone—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000749	0.000804	CcSEcCtD
Nabilone—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000746	0.000801	CcSEcCtD
Nabilone—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00074	0.000794	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000731	0.0162	CbGpPWpGaD
Nabilone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000728	0.000781	CcSEcCtD
Nabilone—Infection—Prednisone—chronic obstructive pulmonary disease	0.000713	0.000765	CcSEcCtD
Nabilone—Shock—Prednisone—chronic obstructive pulmonary disease	0.000706	0.000758	CcSEcCtD
Nabilone—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000701	0.000752	CcSEcCtD
Nabilone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000694	0.000745	CcSEcCtD
Nabilone—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000684	0.000734	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000674	0.0149	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000672	0.0149	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00067	0.0148	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000664	0.0147	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000654	0.0145	CbGpPWpGaD
Nabilone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000654	0.000702	CcSEcCtD
Nabilone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000653	0.000701	CcSEcCtD
Nabilone—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000649	0.000697	CcSEcCtD
Nabilone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000645	0.000692	CcSEcCtD
Nabilone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000632	0.000678	CcSEcCtD
Nabilone—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000624	0.00067	CcSEcCtD
Nabilone—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000623	0.000668	CcSEcCtD
Nabilone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000622	0.000668	CcSEcCtD
Nabilone—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000619	0.000664	CcSEcCtD
Nabilone—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000619	0.000664	CcSEcCtD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000615	0.0136	CbGpPWpGaD
Nabilone—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000614	0.000659	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000603	0.0133	CbGpPWpGaD
Nabilone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000592	0.000635	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000589	0.0131	CbGpPWpGaD
Nabilone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000587	0.00063	CcSEcCtD
Nabilone—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000587	0.00063	CcSEcCtD
Nabilone—CNR2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000585	0.0129	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000574	0.0127	CbGpPWpGaD
Nabilone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000568	0.000609	CcSEcCtD
Nabilone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000568	0.000609	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000535	0.0119	CbGpPWpGaD
Nabilone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000529	0.000568	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000527	0.0117	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000522	0.0116	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000521	0.0115	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000518	0.0115	CbGpPWpGaD
Nabilone—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000515	0.000553	CcSEcCtD
Nabilone—CNR1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000513	0.0114	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000512	0.0113	CbGpPWpGaD
Nabilone—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000508	0.000545	CcSEcCtD
Nabilone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000491	0.000527	CcSEcCtD
Nabilone—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000475	0.000509	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000463	0.0102	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000459	0.0102	CbGpPWpGaD
Nabilone—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000456	0.00049	CcSEcCtD
Nabilone—Rash—Prednisone—chronic obstructive pulmonary disease	0.000453	0.000486	CcSEcCtD
Nabilone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000452	0.000485	CcSEcCtD
Nabilone—Headache—Prednisone—chronic obstructive pulmonary disease	0.00045	0.000483	CcSEcCtD
Nabilone—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000426	0.000458	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.00042	0.0093	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000415	0.00919	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.00041	0.00907	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000406	0.00899	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000401	0.00889	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000392	0.00869	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.00037	0.00819	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000336	0.00744	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.00033	0.00732	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000326	0.00721	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000316	0.007	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000316	0.007	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000308	0.00682	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.0003	0.00664	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.00029	0.00643	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000289	0.0064	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000264	0.00583	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000263	0.00581	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000259	0.00574	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000248	0.00549	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000248	0.00549	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000235	0.00521	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000231	0.00512	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000227	0.00502	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000215	0.00476	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000206	0.00456	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000198	0.00439	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000181	0.00402	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000179	0.00395	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000177	0.00393	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000169	0.00373	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000162	0.00359	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000161	0.00357	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000156	0.00345	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000155	0.00343	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000144	0.00319	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.00014	0.0031	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000139	0.00308	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000127	0.00282	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000126	0.0028	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000122	0.00269	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000119	0.00262	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000113	0.00251	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000113	0.00251	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000108	0.00239	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.58e-05	0.00212	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.3e-05	0.00206	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.11e-05	0.00202	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.88e-05	0.00197	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.67e-05	0.00192	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.48e-05	0.00188	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.78e-05	0.00172	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.52e-05	0.00166	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.15e-05	0.00158	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.14e-05	0.00158	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7e-05	0.00155	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.8e-05	0.00151	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.11e-05	0.00135	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.88e-05	0.0013	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.6e-05	0.00124	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.49e-05	0.00122	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.38e-05	0.00119	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.61e-05	0.00102	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.22e-05	0.000935	CbGpPWpGaD
